The combination of 13N-ammonia and 18F-FDG whole-body PET/CT on the same day for diagnosis of advanced prostate cancer

PURPOSE - The aim of the study was to evaluate the efficacy of N-ammonia and F-fluorodeoxyglucose (F-FDG) PET performed on the same day in the detection of advanced prostate cancer (PC) and its metastases.

PATIENTS AND METHODS - Twenty-six patients with high-risk PC [Gleason score 8-10 or prostate-specific antigen (PSA)>20 ng/ml or clinical tumor extension≥T2c] were recruited into the study.

N-Ammonia and F-FDG PET/CT were performed on the same day (F-FDG followed ammonia, with an interval of a minimum of 2 h). Lesions were interpreted as positive, negative, or equivocal. Patient-based and field-based performance characteristics for both imaging techniques were reported.

RESULTS - There was significant correlation between N-ammonia and F-FDG PET/CT in the detection of primary PC (κ=0. 425, P=0. 001) and no significant difference in sensitivity (60. 2 vs. 54. 5%) and specificity (100 vs. 83. 3%). The maximum standard uptake values and corresponding target-to-background ratio values of the concordantly positive lesions in prostate glands in the two studies did not differ significantly (P=0. 124 and 0. 075, respectively). The sensitivity and specificity of PET imaging using N-ammonia for lymph node metastases were 77. 5 and 96. 3%, respectively, whereas the values were 75 and 44. 4% using F-FDG. The two modalities were highly correlated with respect to the detection of lymph nodes and bone metastases.

CONCLUSION - The concordance between the two imaging modalities suggests a clinical impact of N-ammonia PET/CT in advanced PC patients as well as of F-FDG. N-Ammonia is a useful PET tracer and a complement to F-FDG for detecting primary focus and distant metastases in PC. The combination of these two tracers on the same day can accurately detect advanced PC. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4. 0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially. http://creativecommons. org/licenses/by-nc-nd/4. 0/.

Nuclear medicine communications. 2015 Nov 19 [Epub ahead of print]

Chang Yi, Donglan Yu, Xinchong Shi, Xiangsong Zhang, Ganhua Luo, Qiao He, Xuezhen Zhang

Departments of aNuclear Medicine bMedical Equipment, the First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.

PubMed

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe